




Searching News Database: Jounce Therapeutics
HSMN NewsFeed - 16 May 2022
Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer
Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 27 May 2020
Acquist Therapeutics Announces New Appointments to its Board of Directors
Acquist Therapeutics Announces New Appointments to its Board of Directors
HSMN NewsFeed - 6 Feb 2019
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
HSMN NewsFeed - 3 Nov 2015
Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
HSMN NewsFeed - 23 Apr 2015
Jounce Therapeutics Secures $56 Million in Oversubscribed Series B Financing
Jounce Therapeutics Secures $56 Million in Oversubscribed Series B Financing
HSMN NewsFeed - 10 Jul 2014
Jounce Therapeutics Appoints Richard Murray, Ph.D., to Chief Executive Officer
Jounce Therapeutics Appoints Richard Murray, Ph.D., to Chief Executive Officer